NeoGenomics shares are trading lower after Natera won a preliminary injuction in a patent infringement lawsuit against NeoGenomics' RaDar test.

0.00% Pre

NeoGenomics, Inc.

NEO

0.00

NeoGenomics shares are trading lower after Natera won a preliminary injuction in a patent infringement lawsuit against NeoGenomics' RaDar test.

More This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.

Recommend

Personally, my observation is that (#TASI and #oil) are similar 😉 What have you noticed?

Joby Aviation (JOBY): Assessing Valuation After Recent Share Price Volatility

ESCO Technologies Earnings Preview

How Investors May Respond To Yum China Holdings (YUMC) Accelerating Store Growth and Boosting Capital Returns

RBC Capital Maintains Outperform on Medtronic, Raises Price Target to $118

RBC Capital Maintains Outperform on Kinetik Holdings, Lowers Price Target to $46

Is Bath & Body Works Now Attractive After a 20% Share Price Drop?

In One Chart | Analysts Doubt NVDA's Growth, Market Share Peak - What Happened to Top 20 US Stocks by Turnover on November 21st